Characterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery
| Title | Characterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery |
| Publication Type | Journal Article |
| Year of Publication | 2012 |
| Authors | Kale, SN, Jadhav, AD, Verma, S, Koppikar, SJ, Kaul-Ghanekar, R, Dhole, SD, Ogale, SB |
| Journal | Nanomedicine-Nanotechnology Biology and Medicine |
| Volume | 8 |
| Issue | 4 |
| Pagination | 452-459 |
| Date Published | MAY |
| Type of Article | Article |
| ISSN | 1549-9634 |
| Keywords | Cytotoxicity, drug delivery, Magnetic hyperthermia, Magnetic nanoparticles |
| Abstract | Monodispersed, superparamagnetic nickel cobaltite (NCO) nanoparticles were functionalized using mercaptopropionic acid (MPA). MPA conjugates with NCO forming a metal-carboxylate linkage, with the MPA-MPA interaction occurring via formation of disulfide bonds, leaving another carboxyl end free for additional conjugation. The cytotoxicity studies on NCO-MPA show cell viability of similar to 100% up to a dosage of 40 mu g/mL on SiHa, MCF7, and B16F10 cell lines, and on mouse primary fibroblasts. Time-dependent cell viability studies done for a duration of 72 hours showed the cell lines' viability up to 80% for dosages as high as 80 mu g/mL. Negligible leaching (<5 ppm) of ionic Co or Ni was noted into the delivery medium. Upon subjecting the NCO-MPA dispersion (0.1 mg/mL) to radiofrequency absorption, the nanoparticles were heated to 75 degrees C within 2 minutes, suggesting its promise as a magnetic hyperthermia agent. Furthermore, the amino acid lysine and the drug cephalexin were successfully adducted to the NCO system, suggesting its potential for drug delivery. From the Clinical Editor: NCO-MPA nanopartciles were found to be promising magnetic hyperthermia agents, suggesting potential future clinical applications. (C) 2012 Elsevier Inc. All rights reserved. |
| DOI | 10.1016/j.nano.2011.07.010 |
| Type of Journal (Indian or Foreign) | Foreign |
| Impact Factor (IF) | 6.93 |
